These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10728138)

  • 1. Nonresponders to hepatitis B vaccine.
    Jenson HB
    Postgrad Med; 2000 Mar; 107(3):97-8. PubMed ID: 10728138
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibodies against hepatitis B after vaccination in health workers].
    Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
    Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
    [No Abstract]   [Full Text] [Related]  

  • 3. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
    Marinho RT; Ramalho F; Velosa J
    Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
    Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness to intradermal recombinant hepatitis B vaccine.
    CDR (Lond Engl Wkly); 1991 Oct; 1(43):198. PubMed ID: 1669886
    [No Abstract]   [Full Text] [Related]  

  • 6. Low response to hepatitis B virus vaccine in Costa Rican health-care workers.
    Taylor L; García Z; Herrera G; Luftig RB; Visona KA
    Hepatology; 1998 Feb; 27(2):637. PubMed ID: 9462669
    [No Abstract]   [Full Text] [Related]  

  • 7. Should employees be tested for immunity after hepatitis B vaccination?
    J Occup Med; 1993 Nov; 35(11):1081-2. PubMed ID: 8295028
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
    Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
    JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination and the rate of seroconversion in high risk contacts.
    Sengupta B; Sarkar A; De M; Lahiri P; Bhattacharya DK
    J Indian Med Assoc; 1993 Nov; 91(11):281-2, 285. PubMed ID: 8138648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal hepatitis B virus vaccination for low- or non-responded health-care workers.
    Yasumura S; Shimizu Y; Yasuyama T; Hiroki O; Okada K; Tsukishiro T; Tsuchida T; Higuchi K; Watanabe A
    Acta Med Okayama; 1991 Dec; 45(6):457-9. PubMed ID: 1838229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals.
    Tayal SC; Sankar KN
    AIDS; 1994 Apr; 8(4):558-9. PubMed ID: 7912087
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination against hepatitis B in the Sarajevo Military Hospital].
    Ler Z
    Vojnosanit Pregl; 1991; 48(3):201-5. PubMed ID: 1835220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The experimental efficacy of vaccination with a recombinant yeast vaccine against hepatitis B in combination with immunomodulators].
    Barinskiĭ IF; Lycheva IA; Suetina IA; Posevaia TA; Granovskiĭ NN
    Vopr Virusol; 1994; 39(1):21-4. PubMed ID: 8160443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
    Campos Nizama J
    Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should individuals with anti-HBs as the only marker of infection with hepatitis B receive hepatitis B vaccine?
    MacLeod JE; MacSween HM; Warner HA; Aterman K
    Can J Public Health; 1985; 76(4):229-32. PubMed ID: 2932209
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B and the healthcare worker.
    Ala Nurse; 2007; 34(1):1, 5-6. PubMed ID: 17432324
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine choice and program participation rates when two hepatitis B vaccines are offered.
    Harris AA; Daly-Gawenda D; Hudson EK
    J Occup Med; 1991 Jul; 33(7):804-7. PubMed ID: 1832443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need better hepatitis B vaccines?
    Gerlich WH
    Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to hepatitis B vaccination in high risk population.
    Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
    J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatitis B infection after vaccination.
    Zuckerman JN; Zuckerman AJ
    Lancet; 1995 Jan; 345(8944):261-2; author reply 262-3. PubMed ID: 7823745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.